R. Tomazin et al., Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4(+) T cells, NAT MED, 5(9), 1999, pp. 1039-1043
Citations number
28
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research General Topics
Human cytomegalovirus (HCMV) is a ubiquitous herpesvirus that causes life-t
hreatening disease in patients who are immunosuppressed for bone marrow or
tissue transplantation or who have AIDS (ref. 1). HCMV establishes lifelong
latent infections and, after periodic: reactivation from latency, uses a p
anel of immune evasion proteins to survive and replicate in the face of rob
ust, fully primed host immunity(2,3). Monocyte/macrophages are important ho
st cells for HCMV, serving as a latent reservoir and as a means of dissemin
ation throughout the body(4). Macrophages and other HCMV-permissive cells,
such as endothelial and glial cells, can express MHC class II proteins and
present antigens to CD4+ T lymphocytes. Here, we show that the HCMV protein
US2 causes degradation of two essential proteins in the MHC class II antig
en presentation pathway: HLA-DR-c( and DM-a. This was unexpected, as US2 ha
s been shown to cause degradation of MHC class I (refs. 5,6), which has onl
y limited homology with class II proteins. Expression of US2 in cells reduc
ed or abolished their ability to present antigen to CD4+ T lymphocytes. Thu
s, US2 may allow HCMV-infected macrophages to remain relatively 'invisible'
to CD4+ T cells, a property that would be important after virus reactivati
on.